CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Non Operating Interest Expenses (2012 - 2024)

Updated

CytoDyn's Non Operating Interest Expenses came in at $10.15 million for fiscal Q4 2024 (quarter ended May 31, 2024), down 31.7% from $14.86 million a year earlier but up 19.4% from the prior quarter.

Analysis

CytoDyn (CYDY) Non Operating Interest Expenses (2012 - 2024) Analysis & Trends

For FY2024 (ended May 31, 2024), CytoDyn's Non Operating Interest Expenses was $31.78 million, down 19.0% from FY2023.

  • Non Operating Interest Expenses has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 32.3% (FY2019 to FY2024).
  • Going back by fiscal year, Non Operating Interest Expenses was $39.25 million in FY2023 (-40.0%), $65.42 million in FY2022 (-9.0%), $71.87 million in FY2021 (+10.1%) and $65.29 million in FY2020 (+732.2%).
  • The five-year range for quarterly Non Operating Interest Expenses is $2.94 million (fiscal Q2 2020) to $46.93 million (fiscal Q4 2020).
  • Year-over-year, Non Operating Interest Expenses increased in two of the last eight quarters, with growth averaging 1.2%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in fiscal Q3 2020 (growth of 972.1%), and the weakest in fiscal Q4 2022 (a decline of 89.1%).
  • Business Quant data shows CYDY's Non Operating Interest Expenses at $8.51 million (Q3 2024), $6.17 million (Q2 2024) and $6.96 million (Q1 2024) in the three fiscal quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 CytoDyn 274.70 Mn 274.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2024 10.15 Mn
Feb 29, 2024 8.51 Mn
Nov 30, 2023 6.17 Mn
Aug 31, 2023 6.96 Mn
May 31, 2023 14.86 Mn
Feb 28, 2023 9.78 Mn
Nov 30, 2022 3.33 Mn
Aug 31, 2022 11.28 Mn
May 31, 2022 5.07 Mn
Feb 28, 2022 21.89 Mn
Nov 30, 2021 14.76 Mn
Aug 31, 2021 23.70 Mn
May 31, 2021 46.44 Mn
Feb 28, 2021 6.80 Mn
Nov 30, 2020 13.48 Mn
Aug 31, 2020 5.26 Mn
May 31, 2020 46.93 Mn
Feb 29, 2020 11.26 Mn
Nov 30, 2019 2.94 Mn
Aug 31, 2019 4.16 Mn
API Access

CytoDyn Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CYDY&period=max&api_key=YOUR_API_KEY